Fig. 4: In erythroblasts, mitochondrial bioenergetics changes with the disease severity and the progression of the PD pathology.
From: Orthogonal analysis of mitochondrial function in Parkinson’s disease patients
A Maximal respiration reveals differences between groups with different disease severity and healthy control subjects. Maximal respiration in glucose displays a reduction close to statistical significance in severity group 1 vs. 4 (p = 0.05281) and in severity group 3 vs. 4 (p = 0.05429). B The ratio of OCR in galactose and glucose does not increase in PD specimens. *P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA followed by Dunnett’s multiple comparison test.
